(1)
Griffiths, C.; Papp, K.; Song, M.; Randazzo, B.; Li, S.; Shen, Y.; Han, C.; Blauvelt, A. Maintenance of Response With Guselkumab for up to 3 Years’ Treatment in the Phase 3 VOYAGE 1 Trial of Patients With Plaque Psoriasis. J of Skin 2018, 2, S90.